Tailored Mobile Text Messaging to Reduce Problem Drinking
12. oktober 2016 oppdatert av: Northwell Health
This study is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption; and test and compare it to tailored but static, once a day messaging, gain framed messaging, and ecological momentary assessment only.
Studieoversikt
Status
Fullført
Forhold
Detaljert beskrivelse
The proposed development study entitled, Tailored Mobile Text Messaging to Reduce Problem Drinking is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcohol consumption.
This intervention includes messages tailored to baseline assessment results (including drinking times) that are adaptive to ongoing drinking patterns and goal achievement via interactive ecological momentary assessment (EMA).
Other features include participant initiated help messaging and support network alerts.
We will conduct beta research with 40 problem drinkers to assess messaging preferences and acceptability, and then conduct a pilot test with 10 PDs.
In Stage 1b, we aim to test this intervention and understand the mechanisms of action of different text messaging interventions with 200 problem drinkers over a 12-week period.
We propose to compare four types of messaging: 1) Tailored content and timed messaging adaptive to the participants current state (Stage 1a intervention); 2) Tailored content messaging (not adaptive or timed) sent at 3 pm every day; 3) Untailored consequence based messages sent at 3 pm every day; and 4) Brief feedback and EMA only.
Assessments will be completed at baseline, through weekly EMA via SMS and at week 12 via a web-based follow-up assessment.
Primary outcomes include drinks per drinking day, days of heavy drinking, and average drinks per week as measured through weekly EMA.
Additional outcomes will include drinking related consequences, goal commitment and intervention satisfaction.
Outcomes will be used to modify the intervention and to prepare for a larger Stage 1c RCT.
Studietype
Intervensjonell
Registrering (Faktiske)
174
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
New York
-
Great Neck, New York, Forente stater, 11021
- Feinstein Institute for Medical Research / North Shore-LIJ Health System
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
21 år til 65 år (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
Participants must:
- be fluent and able to read in English at the eighth grade level
- be between the ages of 21 and 65
- have an estimated average weekly consumption of greater than 15 or 24 standard drinks per week for women and men, respectively
- be willing to reduce their drinking to non-hazardous levels
- be willing to provide informed consent
- own a mobile phone and have an active email address and are willing to receive and respond to up to 115 text messages total per month (average = 50)
Exclusion Criteria:
- Participants will be excluded from the study if they
- present with significant substance use or a current substance use disorder (for any substance other than alcohol, nicotine, or caffeine), which is defined as greater than once weekly use in the past month
- present with a serious psychiatric illness or suicide risk as measured by previous inpatient treatment, medications for psychosis or recent suicidality; demonstrate clinically severe alcoholism, as evidenced by physical withdrawal symptoms or a history of serious withdrawal symptoms (e.g., hallucinations, seizures, or delirium tremens), and score greater than 12 on the Short Alcohol Withdrawal Scale (SAWS)
- express a desire or intent to obtain additional substance abuse treatment while in the study
- report a medical condition that precludes drinking any alcohol; or
- demonstrate cognitive impairment as evidenced a score of less than 7 out of 10 on the consent form quiz
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Tailored not adaptive based Intervention
Tailored Text Messaging - not adaptive in the moment and once a day intervention to reduce problem drinking
|
Baseline tailored not adaptive
|
|
Annen: Ecological Momentary Assessment
Mobile Assessment only
|
EMA only
|
|
Eksperimentell: Tailored Adaptive Text Messaging
Tailored Adaptive Text Messaging intervention to reduce problem drinking
|
Adaptive
|
|
Aktiv komparator: Consequence based text messaging
Consequence based Text Messaging intervention to reduce problem drinking
|
Loss Framed
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Days of Heavy Drinking (DHD)
Tidsramme: 12 weeks
|
12 weeks
|
|
Average Drinks per Week (ADW)
Tidsramme: 12 weeks
|
12 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Drinking Related Consequences
Tidsramme: 12 weeks
|
12 weeks
|
|
Goal Commitment
Tidsramme: 12 weeks
|
12 weeks
|
Andre resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Intervention Satisfaction
Tidsramme: 12 weeks
|
12 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Fred Muench, PhD, Feinstein Institute for Medical Research / North Shore-LIJ Health System
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. februar 2014
Primær fullføring (Faktiske)
1. desember 2015
Studiet fullført (Faktiske)
1. august 2016
Datoer for studieregistrering
Først innsendt
20. juni 2013
Først innsendt som oppfylte QC-kriteriene
21. juni 2013
Først lagt ut (Anslag)
24. juni 2013
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
13. oktober 2016
Siste oppdatering sendt inn som oppfylte QC-kriteriene
12. oktober 2016
Sist bekreftet
1. oktober 2016
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AA021502-2
- 1R34AA021502-01 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
IPD-planbeskrivelse
Once cleaned and published will make available
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .